The E7 oncoprotein of human papillomavirus type 16 stabilizes p53 through a mechanism independent of p19(ARF)

Journal of Virology

Volumn 73, Issue 9, 1999, Pages 7590-7598

  Seavey, Scott E ^a   Holubar, Marisa ^a   Saucedo, Leslie J ^a   Perry, Mary Ellen ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; UTERINE CERVIX CANCER; VIRUS ONCOGENE; WART VIRUS;

EID: 0032815930     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.9.7590-7598.1999     Document Type: Article

References (71)

1. Banks, L., C. Edmonds, and K. H. Vousden, 1990. Ability of the HPV16 E7 protein to hind Rb and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5:1383-1389.
2. Blaydes, J. P., and D. Wynford-Thomas. 1998. The proliferation of normal human fibroblasts is dependent upon negative regulation of p53 function by mdm2. Oncogene 16:3317-3322.
3. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
4. Brown, D. R., C. A. Thomas, and S. P. Deb. 1998. The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J. 17:2513-2525.
5. Bull, E. K., S. Chakrabarty, I. Brodsky, and D. S. Haines. 1998. Mdm2-P2 transcript levels predict the functional activity of the p53 tumor suppressor in primary leukemic cells. Oncogene 16:2249-2257.
6. Chellappan, S., V. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-1553.
7. Chen, C.-Y., J. D. Oliner, Q. Zhan, A. J. Fornace, Jr., B. Vogelstein, and M. B. Kastan. 1994. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA 91:2684-2688.
8. Chen, J., V. Marechal, and A. J. Levine. 1993. Mapping of the p53 and mdm-2 interaction domains. Mol. Cell. Biol. 13:4107-4114.
9. Chen, J., J. Lin, and A. J. Levine. 1995. Regulation of transcription functions of the p53 tumor suppressor by the mdm2 oncogene. Mol. Med. 1:142-152.
10. Cheng, S., D.-C. Schmidt-Grimminger, T. Murant, T. R. Broker, and L. Chow. 1995. Differentiation-dependent up-regulation of the human papillo-mavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9:2335-2349.
11. Cistulli, C. A., and W. K. Kaufmann. 1998. p53-dependent signaling sustains DNA replication and enhances clonogenic survival in 254 nm ultraviolet-irradiated human fibroblasts. Cancer Res. 58:1993-2002.
12. Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547-556.
13. Demers, G. W., C. L. Halbert, and D. A. Galloway. 1994. Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology 198:169-174.
14. 1 checkpoint control. Cell 82:675-684.
15. ARF tumor suppressor. Genes Dev. 12:2434-2442.
16. 1 arrest. Cell 76:1013-1023.
17. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1. a potential mediator of p53 tumor suppression. Cell 75:817-825.
18. Ford, J. M., and P. C. Hanawalt. 1997. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J. Biol. Chem. 272:28073-28080.
19. Gire, V., and D. Wynford-Thomas. 1998. Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol. Cell. Biol. 18:1611-1621.
20. Grossman, S. R., M. Perez, A. L. Kung, M. Joseph, C. Mansur, Z.-X. Xiao, S. Kumar, P. M. Howley, and D. M. Livingston. 1998. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2:405-415.
21. Gulliver, G. A., R. L. Herber, A. Liem, and P. F. Lambert. 1997. Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice. J. Virol. 71:5905-5914.
22. Haines, D. S. 1997. The mdm2 proto-oncogene. Leukemia Lymphoma 26: 227-238.
23. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66:2125-2134.
24. Haupt, Y., Y. Barak, and M. Oren. 1996. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15:1596-1606.
25. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature (London) 387:296-299.
26. Heck, D. V., C. L. Yee, P. M. Howley, and K. Munger. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89:4442-4446.
27. ARF with MDM2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53. EMBO J. 18:22-27.
28. Howley, P. M. 1990. Papillomavirinae and their replication, p. 1625-1650. In B. N. Fields and D. M. Knipe (ed.). Fields virology, vol. 2. Raven Press, New York, N.Y.
29. apl protein by human papillomavirus E7 inhibits unscheduled DNA synthesis reactivated in differentiated keratinocytes. Oncogene 17:2027-2038.
30. Jones, D. L., D. A. Thompson, and K. Munger. 1997. Destabilization of the Rb tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 239:97-107.
31. Jones, D. L., D. A. Thompson, E. Suh-Burgmann, M. Grace, and K. Munger. 1999. Expression of the HPV E7 oncopnitein mimics but does not evoke a p53-dependent cellular DNA damage response pathway. Virology 258:406-414.
32. Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in mdm2-deficient mice by absence of p53. Nature (London) 378:206-208.
33. Juven, T., Y. Barak, A. Zauberman, D. L. George, and M. Oren. 1993. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:3411-3416.
34. ARF Cell 91:649-659.
35. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
36. Kubbutat, M. H. G., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature (London) 387:299-303.
37. Lambert, P. F., H. Pan, H. C. Pitot, A. Liem, M. Jackson, and A. E. Griep. 1993. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc. Natl. Acad. Sci. USA 90:5583-5587.
38. Landers, J. E., S. L. Cassel, and D. L. George. 1997. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res. 57:3562-3568.
39. Lane, D. P., C. W. Stephen, C. A. Midgley, A. Sparks, T. R. Hupp, D. A. Daniels, R. Greaves, A. Reid, B. Vojtesek, and S. M. Picksley. 1996. Epitope analysis of the murine p53 tumor suppressor protein. Oncogene 12:2461-2466.
40. Lundgren, K., R. Montes de Oca Luna, Y. B. McNeill, E. P. Emerick, B. Spencer, C. R. Barfield, G. Lozano, M. P. Rosenberg, and C. A. Finlay. 1997. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev. 11:714-725.
41. Martin, K., D. Trouche, C. Hagemeier, T. S. Sorensen, N. B. La Thangue, and T. Kouzarides. 1995. Stimulation of E2F/DP1 transcriptional activity by MDM2 oncoprotein. Nature (London) 375:691-694.
42. Massimi, P., and L. Banks. 1997. Repression of p53 transcriptional activity by the HPV E7 proteins. Virology 227:255-259.
43. Mayo, L. D., J. J. Turchi, and S. J. Berberich. 1997. MDM2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53, Cancer Res. 57:5013-5016.
44. Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
45. Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (London) 378:203-206.
46. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
47. 1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. J. Virol. 71:3451-3457.
48. Munger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor protein. EMBO J. 8:4099-4105.
49. Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature (London) 362:857-860.
50. Pan, H., and A. E. Griep. 1994. Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev. 8:1285-1299.
51. Pear, W. S., G. P. Nolan, M. L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90:8392-8396.
52. Perry, M. E. Unpublished data.
53. Perry, M. E., J. Piette, J. A. Zawadski, D. Harvey, and A. J. Levine. 1993. The mdm2 gene is induced in response to UV light in a p53 dependent manner. Proc. Natl. Acad. Sci. USA 90:11623-11627.
54. Saucedo, L. J., B. P. Carstens, S. E. Seavey, L. D. Albee, and M. E. Perry. 1998. Regulation of transcriptional activation of mdm2 gene by p53 in response to UV radiation. Cell Growth Differ. 9:119-130.
55. Saucedo, L. J., C. D. Myers, and M. E. Perry. 1999. Multiple murine double minute gene 2 (MDM2) proteins are induced by ultraviolet light. J. Biol. Chem. 274:8161-8168.
56. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
57. Shaulian, E., A. Zauberman, D. Ginsberg, and M. Oren. 1992. Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol. Cell. Biol. 12:5581-5592.
58. Sherr, C. J. 1998. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12:2984-2991.
59. Shieh, S.-Y., M. Ikeda, Y. Taya, and C. Prives. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.
60. Song, S., G. A. Gulliver, and P. F. Lambert. 1998. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc. Natl, Acad. Sci. USA 95:2290-2295.
61. Sun, P., P. Dong, K. Dai, G. J. Hannon, and D. Beach. 1998. p53-independent role of MDM2 in TGF-β1 resistance. Science 282:2270-2272.
62. Teoh, G., M. Urashima, A. Ogata, D. Chauhan, J. A. DeCaprio, S. P. Treon, R. L. Schlossman, and K. C. Anderson. 1997. MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells. Blood 90: 1982-1992.
63. Thomas, J. T., and L. A. Laimins. 1998. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint. J. Virol. 72:1131-1137.
64. Thompson, D. A., G. Belinsky, T. H.-T. Chang, D. L. Jones, R. Schlegel, and K. Munger. 1997. The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints. Oncogene 15:3025-3035.
65. Tso, J. Y., X.-H. Sun, T.-h. Kao, K. S. Recce, and R. Wu. 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
66. Vaziri, H., M. D. West, R. C. Allsopp, T. S. Davison, Y.-S. Wu, C. H. Arrowsmith, G. G. Poirier, and S. Benchimol. 1997. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J. 16:6018-6033.
67. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
68. Xiao, Z.-X., J. Chen, A. J. Levine, N. Modjtahedl, J. Xing, W. R. Sellers, and D. M. Livingston. 1995. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature (London) 375:694-698.
69. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by inlerleukin-6. Nature (London) 352:345-347.
70. Zauberman, A., D. Flusberg, Y. Haupt, Y. Barak, and M. Oren. 1995. A functional p53-responsive intronic promoter is contained within the human mdm2 gene. Nucleic Acids Res. 23:2584-2592.
71. Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12: 2424-2433.